NCT02784535View on ClinicalTrials.gov

Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 29, 2016

Primary Completion Date

May 12, 2021

Study Completion Date

June 30, 2023

Conditions
Neurogenic Orthostatic Hypotension
Interventions
DRUG

Atomoxetine

norepinephrine transporter inhibitor

DRUG

Placebo

placebo

Trial Locations (2)

10016

Dysautonomic Center at NYU Langone Medical Center, New York

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

NYU Langone Health

OTHER

lead

Vanderbilt University Medical Center

OTHER

NCT02784535 - Norepinephrine Transporter Blockade, Autonomic Failure (NETAF) | Biotech Hunter | Biotech Hunter